2 results match your criteria: "The School of Medicine of the University of Washington[Affiliation]"
Detection of disseminated prostate cells by reverse transcription-polymerase chain reaction (RT-PCR): technical and clinical aspects.
Int J Cancer
August 1998
Genitourinary Research Cancer Laboratory of the Urology Department, the School of Medicine of the University of Washington, Seattle 98195, USA.
Characterization of 10 new monoclonal antibodies against prostate-specific antigen by analysis of affinity, specificity and function in sandwich assays.
Int J Cancer
June 1997
Urology Department, The School of Medicine of the University of Washington, Seattle 98195, USA.
While prostate-specific antigen (PSA) is already an invaluable marker for prostate cancer, there is continuing demand for new anti-PSA antibodies with specific characteristics, e.g., high sensitivity and specificity and equimolar binding to free PSA (f-PSA) and the PSA-alpha-1-antichymotrypsin complex (PSA-ACT), as well as the ability to distinguish between these 2 immunoreactive forms of PSA.
View Article and Find Full Text PDF